MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

Elena Miñones-Moyano, Sílvia Porta, Georgia Escaramís, Raquel Rabionet, Susana Iraola, Birgit Kagerbauer, Yolanda Espinosa-Parrilla, Isidre Ferrer, Xavier P. Estivill, Eulàlia Martí

Research output: Contribution to journalArticle

270 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are post-transcriptional gene expression regulators, playing key roles in neuronal development, plasticity and disease. Parkinson's disease (PD) is the second most common neurodegenerative disorder, characterized by the presence of protein inclusions or Lewy bodies and a progressive loss of dopaminergic neurons in the midbrain. Here, we have evaluated miRNA expression deregulation in PD brain samples. MiRNA expression profiling revealed decreased expression of miR-34b and miR-34c in brain areas with variable neuropathological affectation at clinical (motor) stages (Braak stages 4 and 5) of the disease, including the amygdala, frontal cortex, substantia nigra and cerebellum. Furthermore, misregulation of miR-34b/c was detected in pre-motor stages (stages 1-3) of the disease, and thus in cases that did not receive any PD-related treatment during life. Depletion of miR-34b or miR-34c in differentiated SH-SY5Y dopaminergic neuronal cells resulted in a moderate reduction in cell viability that was accompanied by altered mitochondrial function and dynamics, oxidative stress and reduction in total cellular adenosin triphosphate content. MiR-34b/c downregulation was coupled to a decrease in the expression of DJ1 and Parkin, two proteins associated to familial forms of PD that also have a role in idiopathic cases. Accordingly, DJ1 and Parkin expression was reduced in PD brain samples displaying strong miR-34b/c downregulation. We propose that early deregulation of miR-34b/c in PD triggers downstream transcriptome alterations underlying mitochondrial dysfunction and oxidative stress, which ultimately compromise cell viability. A better understanding of the cellular pathways controlling and/or controlled by miR-34b/c should allow identification of targets for development of therapeutic approaches.

Original languageEnglish
Article numberddr210
Pages (from-to)3067-3078
Number of pages12
JournalHuman Molecular Genetics
Volume20
Issue number15
DOIs
Publication statusPublished - Aug 2011
Externally publishedYes

Fingerprint

MicroRNAs
Parkinson Disease
Down-Regulation
Brain
Cell Survival
Oxidative Stress
Mitochondrial Dynamics
Lewy Bodies
Neuronal Plasticity
Dopaminergic Neurons
Inclusion Bodies
Frontal Lobe
Substantia Nigra
Mesencephalon
Amygdala
Transcriptome
Neurodegenerative Diseases
Cerebellum
Gene Expression
Proteins

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Miñones-Moyano, E., Porta, S., Escaramís, G., Rabionet, R., Iraola, S., Kagerbauer, B., ... Martí, E. (2011). MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Human Molecular Genetics, 20(15), 3067-3078. [ddr210]. https://doi.org/10.1093/hmg/ddr210

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. / Miñones-Moyano, Elena; Porta, Sílvia; Escaramís, Georgia; Rabionet, Raquel; Iraola, Susana; Kagerbauer, Birgit; Espinosa-Parrilla, Yolanda; Ferrer, Isidre; Estivill, Xavier P.; Martí, Eulàlia.

In: Human Molecular Genetics, Vol. 20, No. 15, ddr210, 08.2011, p. 3067-3078.

Research output: Contribution to journalArticle

Miñones-Moyano, E, Porta, S, Escaramís, G, Rabionet, R, Iraola, S, Kagerbauer, B, Espinosa-Parrilla, Y, Ferrer, I, Estivill, XP & Martí, E 2011, 'MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function', Human Molecular Genetics, vol. 20, no. 15, ddr210, pp. 3067-3078. https://doi.org/10.1093/hmg/ddr210
Miñones-Moyano, Elena ; Porta, Sílvia ; Escaramís, Georgia ; Rabionet, Raquel ; Iraola, Susana ; Kagerbauer, Birgit ; Espinosa-Parrilla, Yolanda ; Ferrer, Isidre ; Estivill, Xavier P. ; Martí, Eulàlia. / MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. In: Human Molecular Genetics. 2011 ; Vol. 20, No. 15. pp. 3067-3078.
@article{05a02edd55c444e288168d3d7862cdf8,
title = "MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function",
abstract = "MicroRNAs (miRNAs) are post-transcriptional gene expression regulators, playing key roles in neuronal development, plasticity and disease. Parkinson's disease (PD) is the second most common neurodegenerative disorder, characterized by the presence of protein inclusions or Lewy bodies and a progressive loss of dopaminergic neurons in the midbrain. Here, we have evaluated miRNA expression deregulation in PD brain samples. MiRNA expression profiling revealed decreased expression of miR-34b and miR-34c in brain areas with variable neuropathological affectation at clinical (motor) stages (Braak stages 4 and 5) of the disease, including the amygdala, frontal cortex, substantia nigra and cerebellum. Furthermore, misregulation of miR-34b/c was detected in pre-motor stages (stages 1-3) of the disease, and thus in cases that did not receive any PD-related treatment during life. Depletion of miR-34b or miR-34c in differentiated SH-SY5Y dopaminergic neuronal cells resulted in a moderate reduction in cell viability that was accompanied by altered mitochondrial function and dynamics, oxidative stress and reduction in total cellular adenosin triphosphate content. MiR-34b/c downregulation was coupled to a decrease in the expression of DJ1 and Parkin, two proteins associated to familial forms of PD that also have a role in idiopathic cases. Accordingly, DJ1 and Parkin expression was reduced in PD brain samples displaying strong miR-34b/c downregulation. We propose that early deregulation of miR-34b/c in PD triggers downstream transcriptome alterations underlying mitochondrial dysfunction and oxidative stress, which ultimately compromise cell viability. A better understanding of the cellular pathways controlling and/or controlled by miR-34b/c should allow identification of targets for development of therapeutic approaches.",
author = "Elena Mi{\~n}ones-Moyano and S{\'i}lvia Porta and Georgia Escaram{\'i}s and Raquel Rabionet and Susana Iraola and Birgit Kagerbauer and Yolanda Espinosa-Parrilla and Isidre Ferrer and Estivill, {Xavier P.} and Eul{\`a}lia Mart{\'i}",
year = "2011",
month = "8",
doi = "10.1093/hmg/ddr210",
language = "English",
volume = "20",
pages = "3067--3078",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "15",

}

TY - JOUR

T1 - MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

AU - Miñones-Moyano, Elena

AU - Porta, Sílvia

AU - Escaramís, Georgia

AU - Rabionet, Raquel

AU - Iraola, Susana

AU - Kagerbauer, Birgit

AU - Espinosa-Parrilla, Yolanda

AU - Ferrer, Isidre

AU - Estivill, Xavier P.

AU - Martí, Eulàlia

PY - 2011/8

Y1 - 2011/8

N2 - MicroRNAs (miRNAs) are post-transcriptional gene expression regulators, playing key roles in neuronal development, plasticity and disease. Parkinson's disease (PD) is the second most common neurodegenerative disorder, characterized by the presence of protein inclusions or Lewy bodies and a progressive loss of dopaminergic neurons in the midbrain. Here, we have evaluated miRNA expression deregulation in PD brain samples. MiRNA expression profiling revealed decreased expression of miR-34b and miR-34c in brain areas with variable neuropathological affectation at clinical (motor) stages (Braak stages 4 and 5) of the disease, including the amygdala, frontal cortex, substantia nigra and cerebellum. Furthermore, misregulation of miR-34b/c was detected in pre-motor stages (stages 1-3) of the disease, and thus in cases that did not receive any PD-related treatment during life. Depletion of miR-34b or miR-34c in differentiated SH-SY5Y dopaminergic neuronal cells resulted in a moderate reduction in cell viability that was accompanied by altered mitochondrial function and dynamics, oxidative stress and reduction in total cellular adenosin triphosphate content. MiR-34b/c downregulation was coupled to a decrease in the expression of DJ1 and Parkin, two proteins associated to familial forms of PD that also have a role in idiopathic cases. Accordingly, DJ1 and Parkin expression was reduced in PD brain samples displaying strong miR-34b/c downregulation. We propose that early deregulation of miR-34b/c in PD triggers downstream transcriptome alterations underlying mitochondrial dysfunction and oxidative stress, which ultimately compromise cell viability. A better understanding of the cellular pathways controlling and/or controlled by miR-34b/c should allow identification of targets for development of therapeutic approaches.

AB - MicroRNAs (miRNAs) are post-transcriptional gene expression regulators, playing key roles in neuronal development, plasticity and disease. Parkinson's disease (PD) is the second most common neurodegenerative disorder, characterized by the presence of protein inclusions or Lewy bodies and a progressive loss of dopaminergic neurons in the midbrain. Here, we have evaluated miRNA expression deregulation in PD brain samples. MiRNA expression profiling revealed decreased expression of miR-34b and miR-34c in brain areas with variable neuropathological affectation at clinical (motor) stages (Braak stages 4 and 5) of the disease, including the amygdala, frontal cortex, substantia nigra and cerebellum. Furthermore, misregulation of miR-34b/c was detected in pre-motor stages (stages 1-3) of the disease, and thus in cases that did not receive any PD-related treatment during life. Depletion of miR-34b or miR-34c in differentiated SH-SY5Y dopaminergic neuronal cells resulted in a moderate reduction in cell viability that was accompanied by altered mitochondrial function and dynamics, oxidative stress and reduction in total cellular adenosin triphosphate content. MiR-34b/c downregulation was coupled to a decrease in the expression of DJ1 and Parkin, two proteins associated to familial forms of PD that also have a role in idiopathic cases. Accordingly, DJ1 and Parkin expression was reduced in PD brain samples displaying strong miR-34b/c downregulation. We propose that early deregulation of miR-34b/c in PD triggers downstream transcriptome alterations underlying mitochondrial dysfunction and oxidative stress, which ultimately compromise cell viability. A better understanding of the cellular pathways controlling and/or controlled by miR-34b/c should allow identification of targets for development of therapeutic approaches.

UR - http://www.scopus.com/inward/record.url?scp=79960135400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960135400&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddr210

DO - 10.1093/hmg/ddr210

M3 - Article

C2 - 21558425

AN - SCOPUS:79960135400

VL - 20

SP - 3067

EP - 3078

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 15

M1 - ddr210

ER -